Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review

Paola Villa, Ve Bounous, Id Amar, F Bernardini, M Giorgi, D Attianese, A Ferrero, Marika D'Oria, Giovanni Scambia

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Background. Advances in the treatment of gynecological cancer have led to improvements in survival but also an increase in menopausal symptoms, especially in young women with premature iatrogenic menopause. Methods. A narrative review was performed to clarify the possibility of prescribing hormone replacement therapy (HRT) after hormone-dependent gynecological cancers (ovarian cancer [OC], cervical adenocarcinoma [AC], and endometrial cancer [EC]). Results. HRT can be prescribed to patients with early-stage, grade I-II OC who experience bothersome menopausal symptoms non-responsive to alternative non-hormone therapy after optimal surgery. Caution should be exercised in administering HRT after serous borderline tumors and endometrioid OC, and HRT is not recommended in low-grade serous OC. HRT is not contraindicated in AC survivors. After surgery for EC, HRT can be prescribed in women with early-stage low-grade EC. There is not enough data to give indications to patients with advanced EC. Conclusions. HRT can be discussed with patients, evaluating the risks and benefits of hormone-dependent gynecological cancer. Counseling should be performed by gynecologic oncologists experienced in the management of these patients.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaJournal of Clinical Medicine
Volume13
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • hormone replacement therapy
  • ovarian cancer
  • menopause
  • endometrial cancer
  • cervical adenocarcinoma

Fingerprint

Entra nei temi di ricerca di 'Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review'. Insieme formano una fingerprint unica.

Cita questo